174 related articles for article (PubMed ID: 20930522)
1. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma.
Jerhammar F; Ceder R; Garvin S; Grénman R; Grafström RC; Roberg K
Cancer Biol Ther; 2010 Dec; 10(12):1244-51. PubMed ID: 20930522
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
[TBL] [Abstract][Full Text] [Related]
3. Integration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer.
Amundson SA; Smilenov LB
Cancer Biol Ther; 2010 Dec; 10(12):1252-5. PubMed ID: 20948301
[No Abstract] [Full Text] [Related]
4. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
5. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
6. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.
Williams PD; Owens CR; Dziegielewski J; Moskaluk CA; Read PW; Larner JM; Story MD; Brock WA; Amundson SA; Lee JK; Theodorescu D
Neoplasia; 2011 Dec; 13(12):1122-31. PubMed ID: 22241958
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
[TBL] [Abstract][Full Text] [Related]
9. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B
Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450
[TBL] [Abstract][Full Text] [Related]
10. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
11. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
12. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
[TBL] [Abstract][Full Text] [Related]
14. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B
Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218
[TBL] [Abstract][Full Text] [Related]
15. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
16. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.
Hanna E; Shrieve DC; Ratanatharathorn V; Xia X; Breau R; Suen J; Li S
Cancer Res; 2001 Mar; 61(6):2376-80. PubMed ID: 11289099
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
Routila J; Suvila K; Grénman R; Leivo I; Westermarck J; Ventelä S
BMC Cancer; 2021 Jul; 21(1):868. PubMed ID: 34320941
[TBL] [Abstract][Full Text] [Related]
19. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
20. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.
Farnebo L; Jerhammar F; Ceder R; Grafström RC; Vainikka L; Thunell L; Grénman R; Johansson AC; Roberg K
J Oral Pathol Med; 2011 Nov; 40(10):739-46. PubMed ID: 21481002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]